The South Korean units of McDonald's, Burger King, and KFC are facing growing skepticism over finding new owners for their franchises here, due to increased difficulties in fundraising and a growing preference among domestic consumers for healthier foods.
According to a food and beverage franchise buyout expert, the pool of buyers who can afford higher prices has become smaller because interest rate hikes have worsened the condition of the acquisition financing market.
He added that the chains' valuations will also be impacted by the concurrent sales attempts.
To avoid harsher market conditions next year, Korean fast-food franchise owners must sell their businesses this year.
Fast food restaurants face significant risks from rising labor and ingredient expenses because it is challenging to raise prices to cover these costs.
The snowballing losses in the fried chicken and hamburger business cost KFC's Korean operator KG Group, which led to a capital impairment in 2020.
KG Group is reportedly desperate to sell the KFC franchise for about 100 billion won, to secure enough cash to buy SsangYong Motor.
Following a failed attempt in 2016, McDonald's US headquarters launched another attempt to sell its Korean business.
However, prospective buyers objected to the conditions of the deal.
Operating losses for McDonald's Korea amounted to 44 billion won in 2019, 48,3 billion won in 2020, and 27.7 billion won in 2021.
The operator of Burger King's Korean location, Affinity Equity Partners, is thought to be more in need of a quick sale because it is a PEF and is required to quickly sell its portfolio companies to disperse profits to its investors.
The Hong Kong-based PEF has been attempting to sell the Burger King's Korean unit in 2016 and its Japanese counterpart for a combined 1 trillion won since late last year.
Insiders in the M&A market, however, expressed doubt about the hamburger business being purchased by a PEF and noted that it will be challenging to increase its valuation until divestiture.


Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal
Middle East War Rattles Global Markets as Oil Tops $100 and Dollar Surges
Innate Pharma Reports 55% Revenue Drop and €49.2M Net Loss for 2025
Merck's $6 Billion Bid for Terns Pharma Signals Bold Oncology Push
WTO Reform Talks Begin in Cameroon Amid Global Trade Tensions
Gold Prices Climb as Middle East Ceasefire Talks Stir Market Optimism
Air Canada Express Crash at LaGuardia: Controller Distracted by Prior Emergency
Asian Markets Rally as Oil Prices Tumble and Middle East Peace Hopes Emerge
Unilever and Magnum Face Defamation Lawsuit Over Ben & Jerry's Board Chair Dismissal
Google's TurboQuant Sends South Korean Chip Stocks Tumbling Amid AI Memory Demand Fears
Merck Raises Growth Outlook, Targets $70 Billion Revenue From New Drugs by Mid-2030s
SK Hynix Eyes Up to $14 Billion U.S. IPO to Fund AI Chip Expansion
Oil Prices Slip as Trump Extends Iran Ceasefire Deadline Amid Ongoing War Fears
Japan Eyes Oil Futures Intervention to Stabilize Yen Amid Middle East Crisis
SMIC Allegedly Supplies Chipmaking Tools to Iran's Military, U.S. Officials Warn 



